A new craze! A new chemical scaffold, namely a staurosporine-like molecule (shown) possessing a pyrazolone core, was found to be highly selective for glycogen synthase kinase 3 over a group of other homologous kinases, including typical cyclin-dependent kinases. This compound gave an impressive dose–response curve for neuroprotection in the homocysteic acid model of oxidative stress (graph shown), and furthermore, blocked chemically induced mania-like effects in mice
Inhibiting glycogen synthase kinase-3 (GSK-3) activity via pharmacological intervention has become a...
Glycogen synthase kinase 3 (GSK-3) is a serine/threonine protein kinase that mediates the addition o...
More than 1 billion people live in areas endemic for leishmaniasis, which is a relevant threat for ...
11 p.-9 fig.-3 tab.Numerous studies have highlighted the implications of the glycogen synthase kinas...
Glycogen synthase kinase-3β, also called tau phosphorylating kinase, is a proline-directed serine/th...
Compound 5 was selected from our in-house library as a suitable starting point for the rational desi...
Compound 5 was selected from our in-house library as a suitable starting point for the rational desi...
An in silico screening procedure was performed to select new inhibitors of glycogen synthase kinase ...
Direct inhibitors of glycogen synthase kinase 3β (GSK3β) have been investigated and reported for the...
Glycogen synthase kinase 3β (GSK-3β) and casein kinase 1δ (CK-1δ) are emerging targets for the treat...
More than 1 billion people live in areas endemic for leishmaniasis, which is a relevant threat for p...
Parkinson's disease (PD) is a devastating neurodegenerative disorder characterized by degeneration o...
Bipolar disorder is characterized by a cycle of mania and depression, which affects approximately 5 ...
For the first time, the in silico design, screening, and in vitro validation of potent GSK-3β type-I...
Parkinson's disease (PD) is a devastating neurodegenerative disorder characterized by degeneration o...
Inhibiting glycogen synthase kinase-3 (GSK-3) activity via pharmacological intervention has become a...
Glycogen synthase kinase 3 (GSK-3) is a serine/threonine protein kinase that mediates the addition o...
More than 1 billion people live in areas endemic for leishmaniasis, which is a relevant threat for ...
11 p.-9 fig.-3 tab.Numerous studies have highlighted the implications of the glycogen synthase kinas...
Glycogen synthase kinase-3β, also called tau phosphorylating kinase, is a proline-directed serine/th...
Compound 5 was selected from our in-house library as a suitable starting point for the rational desi...
Compound 5 was selected from our in-house library as a suitable starting point for the rational desi...
An in silico screening procedure was performed to select new inhibitors of glycogen synthase kinase ...
Direct inhibitors of glycogen synthase kinase 3β (GSK3β) have been investigated and reported for the...
Glycogen synthase kinase 3β (GSK-3β) and casein kinase 1δ (CK-1δ) are emerging targets for the treat...
More than 1 billion people live in areas endemic for leishmaniasis, which is a relevant threat for p...
Parkinson's disease (PD) is a devastating neurodegenerative disorder characterized by degeneration o...
Bipolar disorder is characterized by a cycle of mania and depression, which affects approximately 5 ...
For the first time, the in silico design, screening, and in vitro validation of potent GSK-3β type-I...
Parkinson's disease (PD) is a devastating neurodegenerative disorder characterized by degeneration o...
Inhibiting glycogen synthase kinase-3 (GSK-3) activity via pharmacological intervention has become a...
Glycogen synthase kinase 3 (GSK-3) is a serine/threonine protein kinase that mediates the addition o...
More than 1 billion people live in areas endemic for leishmaniasis, which is a relevant threat for ...